Association between PD-1 inhibitor-related adverse events and frailty assessed by frailty index in lung cancer patients.

Jun Li,Xiaolin Zhang,Shuang Zhou,Ying Zhou,Xinmin Liu

Cancer medicine（2023）

引用 1|浏览11

暂无评分

摘要

Frailty is not associated with severe irAEs, but is related to CIP. Meanwhile, it predicts more than one type of irAEs and a longer hospital stay. Frailty screening has added value to the decision-making process for frail patients eligible for PD-1 inhibitors.

查看译文

关键词

PD-1 inhibitor,frailty,frailty index,immune-related adverse events,lung cancer

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要